News & Analysis on Clinical Trial Services & Contract Research And Development
The Portuguese Minister for Science and Higher Education, Pedro Lynce, confirmed his government's commitment to investing in science with the announcement today that the ministry is considering opening 20 new Ciência Viva (Science Alive) research...
GlaxoSmithKline has entered into a new drug formulation agreement with Flamel Technologies of France that could see the latter firm receive up to $45 million (€41.3m) in licensing fees and milestone payments.
Dow Chemical has agreed for Dowpharma, Dow's pharmaceutical manufacturing services business unit, to supply select, proprietary oligonucleotides to Montreal, Canada-based Topigen Pharmaceuticals for use in its pharmaceutical development programme.
The Eurobarometer 2002 survey on 'Europeans and biotechnology' reveals that despite the impression that Europeans are sceptical about this technology, the majority are optimistic that biotechnololgy will improve our way of life.
Until recently nanotechnologists -- scientists who build devices and materials one atom or molecule at a time -- concentrated almost entirely on electronics, computers, telecommunications, and materials manufacture. Now biomedical nanotechnology, in...